MAVROSTOBART
UNII HT4MAJ8SLE

Substance Identification & Data

This profile provides standardized clinical and technical data for Mavrostobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HT4MAJ8SLE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2928515-12-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HT4MAJ8SLE

CAS Registry Number

2928515-12-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MAVROSTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190695

National Cancer Institute reference terminology for clinical and research data.

INN ID

13259

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-160

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mavrostobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MAVROSTOBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN (1-448) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV1-80*01 (77.6%) -(IGHD) -IGHJ3*01 (85.7%) A128>S (121)/HOMO SAPIENS IGHV3-66*01 (71.4%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10 (CH1 (122-219), HINGE 1-12 S10>P (229) (220-231), CH2 L92 (310) (232-341), CH3 (342-446), CHS (447-448)) (122-448)), (135-220')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-220') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV8-24*01 (86.1%) -(IGHD) -IGHJ5*01 (91.7%) L126>I (112')/HOMO SAPIENS IGKV4-1*01 (80.2%) -(IGHD) -IGHJ2*01 (90.9%) Q120>A (106'), CDR-IMGT (12.3.9) (27'-38'.56'-58'.95'-103')) (1'-113') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN A CELL LINE FROM CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (229-PROLINE), ANTI-(HUMAN CD73 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL PT199 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PT199 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS NT5E (5'-NUCLEOTIDASE ECTO, 5'-NUCLEOTIDASE, NT5, EN, ENT, NTE, CALJA, CD73))

MAVROSTOBART [INN]

MAVROSTOBART [USAN]

PT 199 [WHO-DD]